Published in Cancer Weekly, August 26th, 2003
But antibody levels appear to decrease around ovulation, raising the possibility that the vaccine may be less effective during that time. The findings appeared in the August 6, 2003, issue of the Journal of the National Cancer Institute.
A vaccine is considered promising if it can produce an immune response (determined by levels of antibodies) at disease-specific sites such as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.